Considering the increased importance of NMO in this field and the relatively short time period in which NMO has been regarded as a distinct entity from MS due to its AQP4 antibody specificity, different treatment response and pathology (Wingerchuk et al., 2015), we separately suggested citation classics for NMO in this study. This evidence concerns the gene AQP4 and myeloid sarcoma.